Comparative Safety of Common Immunosuppressant Therapies in Systemic Lupus Erythematosus: A Target Trial Emulation Study. (PubMed, Arthritis Rheumatol) - Sep 18, 2026 - "Initial differences in the infection-related hospitalization risk were attenuated after accounting for time-varying glucocorticoid exposure. These findings highlight glucocorticoid exposure as an important factor associated with serious infection risk, while recognizing that post-baseline glucocorticoid use may reflect both evolving disease activity and a pathway through which therapies influence infection risk."
Journal • Bone Marrow Transplantation • Glomerulonephritis • Immunology • Infectious Disease • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Systemic Lupus Erythematosus • Transplantation
|
|
Ali Duarte-Garcia; Cynthia S Crowson; Mariana González-Treviño; Marlon J Sandino-Bermúdez; Rozalina G McCoy; Yihong Deng
|